Vasileios Karampikas

Dr. Vasileios Karampikas

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2026 in Pathogens
Verified
Journal Article
Open access
PDF file
VKVasileios Karampikas
Vasileios Karampikas
SGStavros Goumenos
Stavros Goumenos
Andreas G. TsantesAndreas G. Tsantes
Andreas G. Tsantes
ITIoannis Trikoupis
Ioannis Trikoupis
PGPanayiotis Gavriil
Panayiotis Gavriil
PPPanayiotis J. Papagelopoulos
Panayiotis J. Papagelopoulos
Background: Periprosthetic joint infection (PJI) is a severe complication following megaprosthetic reconstruction in musculoskeletal oncology. This study aimed to evaluate outcomes of different surgical strategies for PJI in lower-limb megaprostheses and identify factors associated with treatment failure. Methods: We performed a retrospective cohort study of 29 consecutive patients treated for PJI after oncologic megaprosthetic reconstruction. Reinfection was analyzed using cumulative incidence functions (CIFs) with death treated as a competing event. Overall survival was assessed using Kaplan–Meier analysis. Univariable cause-specific Cox regression was performed for exploratory risk-factor analysis. Results: Among 29 patients, coagulase-negative staphylococci and Staphylococcus aureus were the most frequently isolated pathogens, and difficult-to-treat organisms were identified in a substantial proportion of cases. In patients managed with two-stage revision, the cumulative incidence of reinfection was 15% (95% CI: 0–30%) at 1 year and 30% (95% CI: 10–50%) at 2 and 5 years. In the DAIR cohort, the cumulative incidence of reinfection was 25% (95% CI: 0–62.5%) at 1 and 2 years and 37.5% (95% CI: 12.2–75%) at 3 years. Positive reimplantation cultures occurred in 38% of cases and were strongly associated with subsequent treatment failure. Polymicrobial infections were present in 27.5% of cases. Amputation was required in 17.2% of patients, often due to multidrug-resistant organisms or poor soft tissue. Conclusions: Two-stage revision remains the most effective strategy for PJI management in megaprostheses. DAIR may control acute infection but is suboptimal for definitive treatment. Individualized, multidisciplinary approaches are essential to improve outcomes in this high-risk population.

12 October 2026 in Cancers
Verified
Journal Article
Open access
PDF file
PGPanayiotis Gavriil
Panayiotis Gavriil
VKVasileios Karampikas
Vasileios Karampikas
SGStavros Goumenos
Stavros Goumenos
ARAnastasios Roustemis
Anastasios Roustemis
ITIoannis Trikoupis
Ioannis Trikoupis
PPPanayiotis Papagelopoulos
Panayiotis Papagelopoulos
Background/Objectives: Modular megaprosthetic reconstruction is a central limb-salvage strategy after major skeletal resection, but long-term outcomes remain limited. This study aimed to evaluate patient and implant survival, complication burden, Henderson failure modes, and associated risk factors. Methods: We retrospectively analyzed 340 consecutive patients undergoing modular megaprosthetic reconstruction at a tertiary referral center from 2003 to 2024 for primary malignant bone tumors, metastatic disease, or complex revision- or trauma-related indications. Kaplan–Meier methods estimated patient, implant, and complication-free survival. Implant failure and first recorded Henderson failure modes were additionally assessed using competing-risk methods. Cox regression evaluated risk factors, with multivariable modelling focused on Type IV infection. Results: Median follow-up was 5 years. Patient survival was 71.4% at 5 years and 61.3% at 10 years and was poorer in metastatic disease (p < 0.001). Implant survival was 78.0% and 70.3%, respectively. Complications occurred in 133 patients (39.1%). Type IV infection was the most frequent first failure mode (49, 14.4%), followed by Type I soft-tissue failure (40, 11.8%). The cumulative incidence of infection was 14.6% at 5 years and 15.3% at 10 years. Previous surgeries at the operative site (hazard ratio [HR] 2.30 per additional surgery, 95% confidence interval [CI] 1.90–2.80), operative time (HR 1.005/min, 95% CI 1.002–1.008), and diabetes mellitus (HR 2.30, 95% CI 1.25–4.25) were independently associated with infection and remained significant after expanded adjustment. Conclusions: Implant survival remained 70.3% at 10 years, but complications were frequent. Infection was the dominant first failure mode, and prior local surgery, longer operative time, and diabetes identified higher-risk patients. These findings support individualized risk assessment, preventive planning, and long-term surveillance.

2 November 2026 in Prosthesis
Verified
Journal Article
Open access
PDF file
PPPlaton S. Papageorgiou
Platon S. Papageorgiou
DPDimitra Papagelopoulos
Dimitra Papagelopoulos
Aris SopilidisAris Sopilidis
Aris Sopilidis
ATAndreas Tsoupras
Andreas Tsoupras
Rafail C. ChristodoulouRafail C. Christodoulou
Rafail C. Christodoulou
PMPanayiotis D. Megaloikonomos
Panayiotis D. Megaloikonomos
Background: Total joint arthroplasties (TJAs) are well-established orthopedic procedures that provide effective pain relief and restore functional mobility. Although these procedures are generally highly successful, postoperative complications may still occur. This review examined the literature on how machine learning (ML) can predict postoperative complications based on laboratory and clinical parameters for total knee (TKA) and total hip arthroplasty (THA). Methods: A scoping review was conducted and reported in accordance with the PRISMA criteria for scoping reviews (PRISMA-ScR). We searched PubMed/MEDLINE, Scopus, and EMBASE for studies evaluating the use of ML to predict adverse events following TKA and/or THA, using routinely available laboratory values combined with demographics and clinical parameters. Results: The initial search yielded 144 studies, of which 18 were finally deemed eligible for inclusion. Key predictors of complications in the examined studies included hemoglobin, hematocrit, white blood cell count, platelet count, and renal markers. Need for transfusion was the most frequently studied outcome, followed by severe adverse events and postoperative delirium. The ML models, especially gradient boosting machines (GBMs), random forests (RFs), and neural networks (NNs), demonstrated promising discriminative performance in predicting adverse events. Conclusions: Combining laboratory data with demographics and clinical information may improve the accuracy of complication prediction. This review emphasizes the potential of ML analysis of laboratory parameters to create risk assessment tools, which could detect complication risk and potentially improve outcomes for patients undergoing TKA or THA.

12 August 2026 in Antibiotics
Verified
Journal Article
Open access
PDF file
Pavlos AltsitzioglouPavlos Altsitzioglou
Pavlos Altsitzioglou
PGPanayiotis Gavriil
Panayiotis Gavriil
SGStavros Goumenos
Stavros Goumenos
VKVasileios Karampikas
Vasileios Karampikas
ARAnastasios Roustemis
Anastasios Roustemis
VASILEIOS KONTOGEORGAKOSVASILEIOS KONTOGEORGAKOS
VASILEIOS KONTOGEORGAKOS
Background/Objectives: Diagnosis of periprosthetic joint infection (PJI) after total knee arthroplasty remains challenging when standard criteria are inconclusive. This study evaluated the diagnostic accuracy of synovial calprotectin and its prespecified exploratory adjunctive value to preoperative 2018 International Consensus Meeting (ICM) classification. Methods: This prospective single-center diagnostic accuracy study included 35 consecutive patients with primary or revision total knee arthroplasty who underwent synovial calprotectin testing followed by surgery for suspected PJI. Calprotectin was measured using a lateral flow assay with a prespecified threshold of ≥50 mg/L. Diagnostic performance was assessed against a multidisciplinary composite postoperative reference standard that did not incorporate calprotectin. Results: Twenty-one patients were classified as infected and 14 as non-infected. Calprotectin yielded 18 true-positive, 11 true-negative, 3 false-positive, and 3 false-negative results, corresponding to 85.7% sensitivity, 78.6% specificity, 85.7% positive predictive value, 78.6% negative predictive value, and an area under the curve of 0.83. Preoperative ICM correctly classified 26 patients, misclassified one, and left eight inconclusive. Among the inconclusive cases, calprotectin correctly classified all six non-infected patients but neither of the two infected patients. The combined strategy classified all 35 patients, correctly classifying 32 and misclassifying three. Among 10 antibiotic-exposed patients—seven infected and three non-infected—no misclassifications occurred; this finding was descriptive. Conclusions: Synovial calprotectin showed good overall diagnostic performance in this surgically managed cohort. When applied to preoperative ICM-inconclusive cases, it increased classification yield but missed both infected cases and should not be used alone to exclude PJI. Larger blinded multicenter studies are required before routine implementation.